{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:17:15Z","timestamp":1792451835815,"version":"4.5.0"},"reference-count":231,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Renal cell carcinoma (RCC), specifically clear cell renal cell carcinoma (ccRCC), is a metabolic tumor wherein the physiological state of the host is central to tumor development, progression, and therapeutic resistance. Obesity has emerged as one of the major risk factors associated with RCC; however, its impact on RCC is more complex than simply the accumulation of excess body fat. Obesity transforms the renal tumor microenvironment through metabolic rewiring and alterations in inflammation, vasculature, and anti-tumor immunity. The expansion of adipose tissue in obesity alters the renal microenvironment through the production of fatty acids, adipokines, and cytokines in a manner that not only supports tumor growth but also promotes immunosuppression. Increased levels of leptin, resistin, IL-1\u03b2, IL-6, IL-8, and VEGF - together with decreased levels of adiponectin and omentin-1 - promote angiogenesis, stromal remodeling, recruitment of myeloid cells, and evasion of immune checkpoint inhibition. These obesity-driven factors interact with the intrinsic metabolism of ccRCC cells, including lipid accumulation, glycolysis, hypoxic signaling, and metabolic plasticity. Furthermore, obesity reshapes the immune environment through recruitment of MDSCs, polarization of TAMs, dysfunction of DCs, neutrophil-mediated immunosuppression, T cell exhaustion, and increased abundance of regulatory T cells, reinforcing an immunosuppressive state. These effects of obesity in RCC are particularly relevant in the context of the obesity paradox, wherein obesity has been associated with improved treatment outcomes, which are not uniformly observed across RCC cohorts. These differences may reflect the limitations of body mass index as a biological indicator of obesity, together with variations in systemic inflammation, body composition, and treatment context. Here, we summarize current knowledge on obesity-driven immunometabolic rewiring in RCC and outline key priorities for the field, including obesity-relevant preclinical models, biomarkers of visceral adiposity and systemic inflammation, and clinical trials targeting immunometabolism.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1866875","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:46:39Z","timestamp":1781156799000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Henry N.","family":"Ogbonna","sequence":"first","affiliation":[{"name":"Graduate Biomedical Sciences, Pathology, Pharmacology, and Physiology Theme, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]},{"name":"Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky","place":["Lexington, KY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyse A.","family":"Norian","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky","place":["Lexington, KY, United States"]},{"name":"Markey Cancer Center, University of Kentucky","place":["Lexington, KY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.06.005","article-title":"Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors","volume":"88","author":"Larcher","year":"2025","journal-title":"Eur Urol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.path.2015.09.003","article-title":"Adult renal cell carcinoma: a review of established entities from morphology to molecular genetics","volume":"8","author":"Hirsch","year":"2015","journal-title":"Surg Pathol Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113063","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"43","author":"Ricketts","year":"2024","journal-title":"Cell Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-011-9810-1","article-title":"Rare (<1%) histological subtypes of renal cell carcinoma: an update","volume":"37","author":"Shanbhogue","year":"2012","journal-title":"Abdom Imaging"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3233\/cbm-2011-0176","article-title":"Renal cell carcinoma","volume":"9","author":"Srivastava","year":"2011","journal-title":"Cancer Biomarkers"},{"key":"B7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.semcdb.2016.09.002","article-title":"Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: a braided cancer river model of kidney cancer","volume":"64","author":"Hsieh","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/mou.0000000000001229","article-title":"Adjuvant treatment for renal cell carcinoma:\u00a0current status and future","volume":"35","author":"Leung","year":"2025","journal-title":"Curr Opin Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.230356","article-title":"Advances in the management of renal cell carcinoma","volume":"196","author":"Cardenas","year":"2024","journal-title":"Cmaj"},{"key":"B10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00262-023-03621-1","article-title":"Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data","volume":"73","author":"Yanagisawa","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102528","article-title":"Post nephrectomy management of localized renal cell carcinoma. from risk stratification to therapeutic evidence in an evolving clinical scenario","volume":"115","author":"Ciccarese","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01662-5","article-title":"Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression","volume":"56","author":"Hu","year":"2024","journal-title":"Nat Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1195500","article-title":"Metabolic reprogramming of clear cell renal cell carcinoma","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.727778","article-title":"The uniqueness of clear cell renal cell carcinoma: summary of the process and abnormality of glucose metabolism and lipid metabolism in ccRCC","volume":"11","author":"Qi","year":"2021","journal-title":"Front Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-21-0211","article-title":"Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma","volume":"11","author":"Riscal","year":"2021","journal-title":"Cancer Discov"},{"key":"B16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12032-024-02484-5","article-title":"Lipid metabolism reprogramming in renal cell carcinomas","volume":"41","author":"Abduljabbar","year":"2024","journal-title":"Med Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2012.06.001","article-title":"The VHL\/HIF axis in clear cell renal carcinoma","volume":"23","author":"Shen","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"B18","article-title":"Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis","volume":"54","author":"Takahashi","year":"1994","journal-title":"Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)60229-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2023.04.011","article-title":"Von-Hippel Lindau and hypoxia-inducible factor at the\u00a0center of renal cell carcinoma biology","volume":"37","author":"Shirole","year":"2023","journal-title":"Hematol Oncol Clin North Am"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(08)60269-x","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000012860","article-title":"The association between BMI and kidney cancer risk: an updated dose-response meta-analysis in accordance with PRISMA guideline","volume":"97","author":"Liu","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm137","article-title":"Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women\u2019s Health Initiative (United States)","volume":"166","author":"Luo","year":"2007","journal-title":"Am J Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0500-z","article-title":"Obesity, abdominal obesity and subsequent risk of kidney cancer: a cohort study of 23.3 million East Asians","volume":"121","author":"Nam","year":"2019","journal-title":"Br J Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.03.107","article-title":"Visceral obesity in predicting oncologic outcomes of localized renal cell carcinoma","volume":"192","author":"Park","year":"2014","journal-title":"J Urol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/bju.12592","article-title":"Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China","volume":"114","author":"Wang","year":"2014","journal-title":"BJU Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.04.032","article-title":"Obesity in relation to renal cell carcinoma incidence and survival in three prospective studies","volume":"82","author":"Graff","year":"2022","journal-title":"Eur Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer--viewpoint of the IARC working group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057475","article-title":"Metabolic factors associated with risk of renal cell carcinoma","volume":"8","author":"H\u00e4ggstr\u00f6m","year":"2013","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070703","article-title":"Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes","volume":"8","author":"Weitman","year":"2013","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.55","article-title":"Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice","volume":"16","author":"Kim","year":"2008","journal-title":"Obes (Silver Spring)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100587","article-title":"Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth","volume":"189","author":"James","year":"2012","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118784","article-title":"Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2","volume":"10","author":"Hale","year":"2015","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30797-1","article-title":"Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study","volume":"21","author":"Sanchez","year":"2020","journal-title":"Lancet Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.euros.2022.03.002","article-title":"Impact of body mass index on survival outcomes of patients with metastatic renal cell carcinoma in the immuno-oncology era: a systematic review and meta-analysis","volume":"39","author":"Takemura","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2022.08.001","article-title":"Impact of body mass index on outcomes in an Asian population of advanced renal cell carcinoma and urothelial carcinoma treated with immune checkpoint inhibitors","volume":"21","author":"Ishihara","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.0019","article-title":"Assessment of immune checkpoint inhibitors and genomic alterations by body mass index in advanced renal cell carcinoma","volume":"7","author":"Lalani","year":"2021","journal-title":"JAMA Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/j.clgc.2023.03.006","article-title":"Clinico-pathological features influencing the prognostic role of body mass index in patients with advanced renal cell carcinoma treated by immuno-oncology combinations (ARON-1)","volume":"21","author":"Santoni","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102295","article-title":"Diet-induced obesity impairs outcomes and induces multi-factorial deficiencies in effector T cell responses following anti-CTLA-4 combinatorial immunotherapy in renal tumor-bearing mice","volume":"13","author":"Turbitt","year":"2021","journal-title":"Cancers"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000725","article-title":"Obesity diminishes response to PD-1-based immunotherapies in renal cancer","volume":"8","author":"Boi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04518-2","article-title":"A single-cell atlas of human and mouse white adipose tissue","volume":"603","author":"Emont","year":"2022","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1995.268.4.E588","article-title":"Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects","volume":"268","author":"Potts","year":"1995","journal-title":"Am J Physiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"16718","DOI":"10.1038\/s41598-022-20877-2","article-title":"Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma","volume":"12","author":"Maurits","year":"2022","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21666","article-title":"Human renal adipose tissue induces the invasion and progression of renal cell carcinoma","volume":"8","author":"Campo-Verde-Arbocco","year":"2017","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.1038\/s41598-022-12746-9","article-title":"Renal peritumoral adipose tissue undergoes a browning process and stimulates the expression of epithelial-mesenchymal transition markers in human renal cells","volume":"12","author":"Ferrando","year":"2022","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1652589","article-title":"Proangiogenic effects of peritumoral adipose tissue in kidney cancer","volume":"12","author":"Ferrando","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200412000-00007","article-title":"The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas","volume":"28","author":"Bonsib","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000173942.19990.40","article-title":"Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma","volume":"174","author":"Thompson","year":"2005","journal-title":"J Urol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31829a85d0","article-title":"Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations","volume":"37","author":"Trpkov","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00756.x","article-title":"Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells","volume":"99","author":"Chuang","year":"2008","journal-title":"Cancer Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.5387\/fms.2018-15","article-title":"Interleukin-6 induces drug resistance in renal cell carcinoma","volume":"64","author":"Ishibashi","year":"2018","journal-title":"Fukushima J Med Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-12-0294","article-title":"Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment","volume":"72","author":"Zhang","year":"2012","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-13-0926","article-title":"Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis","volume":"73","author":"Arendt","year":"2013","journal-title":"Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10549-014-3223-0","article-title":"Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production","volume":"149","author":"Bowers","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13782","article-title":"Obesity alters the fitness of peritumoral adipose tissue, exacerbating tumor invasiveness in renal cancer through the induction of ADAM12 and CYP1B1","volume":"19","author":"Torabinejad","year":"2025","journal-title":"Mol Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.786981","article-title":"Fat attenuation index of renal cell carcinoma reveals biological characteristics and survival outcome","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000047247","article-title":"Impact of metabolic syndrome and its components on the tumor aggressiveness of renal cell carcinoma","volume":"105","author":"Dogan","year":"2026","journal-title":"Med (Baltimore)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.beem.2013.11.003","article-title":"Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic \u03b2 cells and adipocytes","volume":"28","author":"Tao","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.jpha.2023.12.003","article-title":"New advances of adiponectin in regulating obesity and related metabolic syndromes","volume":"14","author":"Han","year":"2024","journal-title":"J Pharm Anal"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1207","article-title":"Weight-loss diets, adiponectin, and changes in cardiometabolic risk in the 2-year POUNDS lost trial","volume":"101","author":"Ma","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0403382101","article-title":"T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30\/adiponectin","volume":"101","author":"Hug","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"B64","article-title":"Adiponectin inhibits colorectal cancer cell growth through the AMPK\/mTOR pathway","volume":"34","author":"Sugiyama","year":"2009","journal-title":"Int J Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.04.076","article-title":"Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells","volume":"345","author":"Dieudonne","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/me.2009-0498","article-title":"Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation","volume":"24","author":"Kim","year":"2010","journal-title":"Mol Endocrinol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22526","article-title":"Low adiponectin levels are associated with renal cell carcinoma: a case-control study","volume":"120","author":"Spyridopoulos","year":"2007","journal-title":"Int J Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs322","article-title":"Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers","volume":"34","author":"Liao","year":"2012","journal-title":"Carcinogenesis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hym158","article-title":"Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma","volume":"38","author":"Horiguchi","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.5408","article-title":"Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma","volume":"13","author":"Zhang","year":"2017","journal-title":"Oncol Lett"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.06.040","article-title":"Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway","volume":"176","author":"Horiguchi","year":"2006","journal-title":"J Urol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.01169","article-title":"Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways","volume":"13","author":"Sharma","year":"2006","journal-title":"Endocrine-Related Cancer Endocr Relat Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.01053.x","article-title":"Leptin induces functional activation of cyclooxygenase-2 through JAK2\/STAT3, MAPK\/ERK, and PI3K\/AKT pathways in human endometrial cancer cells","volume":"100","author":"Gao","year":"2009","journal-title":"Cancer Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.7.11.6837","article-title":"Concomitant activation of the JAK\/STAT3 and ERK1\/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells","volume":"7","author":"Li","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.06.039","article-title":"Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma","volume":"176","author":"Horiguchi","year":"2006","journal-title":"J Urol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/biom11030431","article-title":"Leptin is associated with poor clinical outcomes and promotes clear cell renal cell carcinoma progression","volume":"11","author":"Fan","year":"2021","journal-title":"Biomolecules"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-20-0358","article-title":"Oxidized lipoproteins promote resistance to cancer immunotherapy independent of patient obesity","volume":"9","author":"Khojandi","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action","volume":"290","author":"Yang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3390\/biom11111609","article-title":"Circulating omentin-1 as a biomarker at the intersection of postmenopausal breast cancer occurrence and cardiometabolic risk: an observational cross-sectional study","volume":"11","author":"Christodoulatos","year":"2021","journal-title":"Biomolecules"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2012.11.016","article-title":"Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells","volume":"698","author":"Zhang","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2018.11.10","article-title":"Prognostic biomarkers in renal cell carcinoma: is there a relationship with obesity","volume":"8","author":"Rajandram","year":"2018","journal-title":"Trans Andrology Urol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.09.004","article-title":"Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer","volume":"77","author":"Shen","year":"2016","journal-title":"Cytokine"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.34133\/research.0326","article-title":"Resistin regulates inflammation and insulin resistance in humans via the endocannabinoid system","volume":"7","author":"Yang","year":"2024","journal-title":"Res (Wash D C)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2016.10.002","article-title":"Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-\u03baB signaling pathways: implications for intervertebral disc degeneration","volume":"25","author":"Li","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"B85","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12974-025-03522-3","article-title":"The Resistin\/TLR4\/miR-155-5p axis: a novel signaling pathway in the onset of hypothalamic neuroinflammation","volume":"22","author":"Pr\u00e9vost","year":"2025","journal-title":"J Neuroinflamm"},{"key":"B86","doi-asserted-by":"publisher","first-page":"544.e25","DOI":"10.1016\/j.urolonc.2017.05.005","article-title":"Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer","volume":"35","author":"Kallio","year":"2017","journal-title":"Urol Oncol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41467-017-01965-8","article-title":"HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism","volume":"8","author":"Du","year":"2017","journal-title":"Nat Commun"},{"key":"B88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40170-022-00290-z","article-title":"ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma","volume":"10","author":"Klasson","year":"2022","journal-title":"Cancer Metab"},{"key":"B89","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10555-021-09996-w","article-title":"Lipid metabolism reprogramming in renal cell carcinoma","volume":"41","author":"Heravi","year":"2022","journal-title":"Cancer Metastasis Rev"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-026-01411-0","article-title":"Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment","volume":"23","author":"Du","year":"2026","journal-title":"Cell Mol Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102513","article-title":"Lipid metabolism of clear cell renal cell carcinoma predicts survival and affects intratumoral CD8 T cells","volume":"61","author":"Simeth","year":"2025","journal-title":"Transl Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-12-3249","article-title":"Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma","volume":"19","author":"von Roemeling","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/srep28932","article-title":"Lipidomic signatures and associated transcriptomic profiles of clear cell renal cell carcinoma","volume":"6","author":"Saito","year":"2016","journal-title":"Sci Rep"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog Lipid Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118006","article-title":"Targeting polyunsaturated fatty acids desaturase FADS1 inhibits renal cancer growth via ATF3-mediated ER stress response","volume":"186","author":"Heravi","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1773666","article-title":"Increased expression of CD36 and CD163 in clear cell renal cell carcinoma suggests an association between lipid transport and an \u201cM2-like\u201d macrophage phenotype","volume":"17","author":"Bouraoui","year":"2026","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00543.2014","article-title":"Fatty acid-binding protein 5 regulates diet-induced obesity via GIP secretion from enteroendocrine K cells in response to fat ingestion","volume":"308","author":"Shibue","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4721","article-title":"FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K\/AKT signaling pathway","volume":"54","author":"Lv","year":"2019","journal-title":"Int J Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.09.060","article-title":"Detection of transcript for brain-type fatty acid-binding protein in tumor and urine of patients with renal cell carcinoma","volume":"69","author":"Teratani","year":"2007","journal-title":"Urology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00109-019-01863-0","article-title":"The vital role of ATP citrate lyase in chronic diseases","volume":"98","author":"Khwairakpam","year":"2020","journal-title":"J Mol Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8211","article-title":"Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in vitro","volume":"15","author":"Teng","year":"2018","journal-title":"Oncol Lett"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Creighton","year":"2013","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102056","article-title":"The prognostic value and its relationship with immune infiltration of ACLY in clear cell renal cell carcinoma","volume":"47","author":"Yin","year":"2024","journal-title":"Transl Oncol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.66.7311","article-title":"Body mass index and metastatic renal cell carcinoma: Clinical and biological correlations","volume":"34","author":"Albiges","year":"2016","journal-title":"J Clin Oncol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166231","article-title":"High expression of stearoyl-CoA desaturase 1 predicts poor prognosis in patients with clear-cell renal cell carcinoma","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"B106","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12672-025-02255-2","article-title":"FADS1, a lipid metabolism-related diagnostic biomarker in KIRC","volume":"16","author":"Yang","year":"2025","journal-title":"Discov Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109750","article-title":"ECHS1 suppresses renal cell carcinoma development through inhibiting mTOR signaling activation","volume":"123","author":"Wang","year":"2020","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-14-1507","article-title":"HIF2\u03b1-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma","volume":"5","author":"Qiu","year":"2015","journal-title":"Cancer Discov"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15639","article-title":"Adipophilin as prognostic biomarker in clear cell renal cell carcinoma","volume":"8","author":"Tolkach","year":"2017","journal-title":"Oncotarget"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality","volume":"3","author":"Chan","year":"2011","journal-title":"Sci Transl Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nature13557","article-title":"Fructose-1,6-bisphosphatase opposes renal carcinoma progression","volume":"513","author":"Li","year":"2014","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3823","article-title":"Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma","volume":"6","author":"Lucarelli","year":"2015","journal-title":"Oncotarget"},{"key":"B113","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cmet.2018.07.020","article-title":"Isotope tracing of human clear cell renal cell carcinomas demonstrates suppressed glucose oxidation in vivo","volume":"28","author":"Courtney","year":"2018","journal-title":"Cell Metab"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23056","article-title":"The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation","volume":"8","author":"Bianchi","year":"2017","journal-title":"Oncotarget"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1172\/jci173934","article-title":"VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis","volume":"134","author":"Wolf","year":"2024","journal-title":"J Clin Invest"},{"key":"B116","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41419-025-07418-1","article-title":"S100A2 promotes clear cell renal cell carcinoma tumor metastasis through regulating GLUT2 expression","volume":"16","author":"Deng","year":"2025","journal-title":"Cell Death Dis"},{"key":"B117","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13046-021-02103-5","article-title":"PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance","volume":"40","author":"Feng","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B118","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1038\/s41467-022-32871-3","article-title":"Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2","volume":"13","author":"Feng","year":"2022","journal-title":"Nat Commun"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85103","article-title":"Diet-induced loss of adipose hexokinase 2 correlates with hyperglycemia","volume":"12","author":"Shimobayashi","year":"2023","journal-title":"Elife"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1452861","article-title":"The correlation of HK2 gene expression with the occurrence, immune cell infiltration, and prognosis of renal cell carcinoma","volume":"2022","author":"Liu","year":"2022","journal-title":"Dis Markers"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.58295","article-title":"Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte\/macrophage infiltration into the clear cell renal cell carcinoma microenvironment","volume":"17","author":"Xu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402070R","article-title":"PFKFB3 protein in adipose tissue contributes to whole body glucose homeostasis","volume":"38","author":"Griesel","year":"2024","journal-title":"FASEB J"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09183-2","article-title":"Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma","volume":"22","author":"Li","year":"2022","journal-title":"BMC Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104268","article-title":"Differing impact of phosphoglycerate mutase 1-deficiency on brown and white adipose tissue","volume":"25","author":"Yoshida","year":"2022","journal-title":"iScience"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3724\/sp.j.1008.2012.00690","article-title":"Expression of PGAM1 in renal clear cell carcinoma and its clinical significance","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7637","article-title":"LDHA promotes tumor metastasis by facilitating epithelial-mesenchymal transition in renal cell carcinoma","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol Med Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-009-0750-3","article-title":"Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes","volume":"459","author":"P\u00e9rez de Heredia","year":"2010","journal-title":"Pflugers Arch"},{"key":"B128","doi-asserted-by":"publisher","first-page":"311.e15","DOI":"10.1016\/j.urolonc.2018.03.014","article-title":"Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis","volume":"36","author":"Cao","year":"2018","journal-title":"Urol Oncol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/139239","article-title":"Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines","volume":"2013","author":"Makki","year":"2013","journal-title":"ISRN Inflammation"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.3390\/cancers15082212","article-title":"Inflammatory networks in renal cell carcinoma","volume":"15","author":"Kruk","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107765","article-title":"Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies","volume":"96","author":"Ghanbari","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233795","article-title":"Obesity induces limited changes to systemic and local immune profiles in treatment-naive human clear cell renal cell carcinoma","volume":"15","author":"Gibson","year":"2020","journal-title":"PloS One"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-15-1823","article-title":"Myeloid-derived suppressor cell subset accumulation in renal cell carcinoma parenchyma is associated with intratumoral expression of IL1\u03b2, IL8, CXCL5, and Mip-1\u03b1","volume":"23","author":"Najjar","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/cam4.7","article-title":"Interleukin-1\u03b2 mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein \u03b2","volume":"1","author":"Petrella","year":"2012","journal-title":"Cancer Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-20-1610","article-title":"Blocking IL1 beta promotes tumor regression and remodeling of the myeloid compartment in a renal cell carcinoma model: Multidimensional analyses","volume":"27","author":"Aggen","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00306.2020","article-title":"The controversial role of IL-6 in adipose tissue on obesity-induced dysregulation of glucose metabolism","volume":"319","author":"Wueest","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13332","article-title":"Interleukin-6\/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy","volume":"108","author":"Kitamura","year":"2017","journal-title":"Cancer Sci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030712","article-title":"Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production","volume":"7","author":"Fitzgerald","year":"2012","journal-title":"PloS One"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2019.100127","article-title":"Elevated plasma interleukin 6 predicts poor response in patients treated with sunitinib for metastatic clear cell renal cell carcinoma","volume":"19","author":"Pilskog","year":"2019","journal-title":"Cancer Treat Res Commun"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.2","article-title":"p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-\u03baB\/IL-6 activation in renal cell carcinoma","volume":"6","author":"Zhu","year":"2015","journal-title":"Cell Death Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-21-3749","article-title":"IL6 and CCL18 mediate cross-talk between VHL-deficient kidney cells and macrophages during development of renal cell carcinoma","volume":"82","author":"Nguyen","year":"2022","journal-title":"Cancer Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.3390\/cancers14235985","article-title":"High serum levels of IL-6 predict poor responses in patients treated with pembrolizumab plus axitinib for advanced renal cell carcinoma","volume":"14","author":"Sang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B143","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41392-025-02486-3","article-title":"Adipocytes orchestrate obesity-related chronic inflammation through \u03b22-microglobulin","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C800207200","article-title":"CXCL8\/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3\/Bcl10\/Malt1) complex","volume":"284","author":"Martin","year":"2009","journal-title":"J Biol Chem"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/srep05911","article-title":"The IL-8\/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases","volume":"4","author":"Chen","year":"2014","journal-title":"Sci Rep"},{"key":"B146","doi-asserted-by":"publisher","first-page":"oyaf254","DOI":"10.1093\/oncolo\/oyaf254","article-title":"Interleukin-8 as a potential prognostic biomarker in renal cell carcinoma: a systematic review and meta-analysis","volume":"30","author":"Zacchi","year":"2025","journal-title":"Oncologist"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00626.2010","article-title":"Regulation of HIF-1{alpha} activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia","volume":"300","author":"He","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041316","article-title":"Downstream targets of VHL\/HIF-\u03b1 signaling in renal clear cell carcinoma progression: mechanisms and therapeutic relevance","volume":"15","author":"Mazumder","year":"2023","journal-title":"Cancers"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161366","article-title":"Endothelial VEGFR2-PLC\u03b3 signaling regulates vascular permeability and antitumor immunity through eNOS\/Src","volume":"133","author":"Sj\u00f6berg","year":"2023","journal-title":"J Clin Invest"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12624","article-title":"Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma","volume":"7","author":"Wallin","year":"2016","journal-title":"Nat Commun"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32361","article-title":"Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinoma","volume":"125","author":"Mantia","year":"2019","journal-title":"Cancer"},{"key":"B152","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2019","journal-title":"Br J Cancer"},{"key":"B153","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduction Targeted Ther"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-08-1921","article-title":"Arginase I\u2013producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes","volume":"69","author":"Rodriguez","year":"2009","journal-title":"Cancer Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3892\/ol.2020.12410","article-title":"Dual roles of myeloid-derived suppressor cells induced by Toll-like receptor signaling in cancer (review)","volume":"21","author":"Zhou","year":"2021","journal-title":"Oncol Lett"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005551","article-title":"HSP90\u03b1 induces immunosuppressive myeloid cells in melanoma via TLR4 signaling","volume":"10","author":"Arkhypov","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2420005122","article-title":"Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells","volume":"122","author":"Zhang","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.977485","article-title":"Adipose tissue macrophage in obesity-associated metabolic diseases","volume":"13","author":"Yao","year":"2022","journal-title":"Front Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1212101","article-title":"Extracellular vesicles in renal cell carcinoma: challenges and opportunities coexist","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201608024","article-title":"VHL promotes immune response against renal cell carcinoma via NF-\u03baB-dependent regulation of VCAM-1","volume":"216","author":"Labrousse-Arias","year":"2017","journal-title":"J Cell Biol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-21-0345","article-title":"Endothelial reprogramming stimulated by Oncostatin M promotes inflammation and tumorigenesis in VHL-deficient kidney tissue","volume":"81","author":"Nguyen-Tran","year":"2021","journal-title":"Cancer Res"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-00626-6","article-title":"Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Death Differ"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.70289","article-title":"Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway","volume":"18","author":"Zhang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07529-3","article-title":"Obesity induces PD-1 on macrophages to suppress anti-tumour immunity","volume":"630","author":"Bader","year":"2024","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092450","article-title":"Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells","volume":"9","author":"Chen","year":"2014","journal-title":"PloS One"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1274","article-title":"Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients","volume":"61","author":"Bertola","year":"2012","journal-title":"Diabetes"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-010-0833-1","article-title":"Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy","volume":"59","author":"Schreibelt","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B169","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/jc.2013-3092","article-title":"Toll-like receptor status in obesity and metabolic syndrome: a translational perspective","volume":"99","author":"Jialal","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B170","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/eji.201343592","article-title":"Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells","volume":"44","author":"Moraes-Vieira","year":"2014","journal-title":"Eur J Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2018-0175","article-title":"Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis","volume":"11","author":"Nunno","year":"2019","journal-title":"Immunotherapy"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0315-0","article-title":"Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma","volume":"6","author":"Lalani","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199719","article-title":"Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma","volume":"13","author":"Azuma","year":"2018","journal-title":"PloS One"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1755401","article-title":"Tumor-associated neutrophils in renal cell carcinoma","volume":"17","author":"Kovaleva","year":"2026","journal-title":"Front Immunol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2020.1747731","article-title":"The immunosuppressive phenotype of tumor-infiltrating neutrophils is associated with obesity in kidney cancer patients","volume":"9","author":"Margaroli","year":"2020","journal-title":"Oncoimmunology"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1177\/15330338251382839","article-title":"A prognostic risk signature based on myeloid-derived suppressor cells and regulatory T cells in clear cell renal cell carcinoma","volume":"24","author":"Xu","year":"2025","journal-title":"Technol Cancer Res Treat"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000528","article-title":"Cell death induced by cytotoxic CD8+ T cells is immunogenic and primes caspase-3-dependent spread immunity against endogenous tumor antigens","volume":"8","author":"Jaime-Sanchez","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B178","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"B179","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B180","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1038\/s41598-021-83767-z","article-title":"Immune classification of clear cell renal cell carcinoma","volume":"11","author":"Su","year":"2021","journal-title":"Sci Rep"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93411","article-title":"Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma","volume":"2","author":"Siska","year":"2017","journal-title":"JCI Insight"},{"key":"B182","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","article-title":"An immune atlas of clear cell renal cell carcinoma","volume":"169","author":"Chevrier","year":"2017","journal-title":"Cell"},{"key":"B183","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ccell.2021.02.013","article-title":"Progressive immune dysfunction with advancing disease stage in renal cell carcinoma","volume":"39","author":"Braun","year":"2021","journal-title":"Cancer Cell"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-12-0588","article-title":"Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008368","article-title":"NKG2A+CD8+ T cells\u00a0infiltration determines immunosuppressive contexture and inferior response to\u00a0immunotherapy in clear cell renal cell carcinoma","volume":"12","author":"Qiu","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B186","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.kint.2020.08.028","article-title":"Immune evasion in renal cell carcinoma: biology, clinical translation, future directions","volume":"99","author":"Wang","year":"2021","journal-title":"Kidney Int"},{"key":"B187","article-title":"Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity","volume":"61","author":"Nakano","year":"2001","journal-title":"Cancer Res"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front Immunol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","article-title":"Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures","volume":"17","author":"\u015eenbabao\u011flu","year":"2016","journal-title":"Genome Biol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-007-0318-z","article-title":"Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival","volume":"56","author":"Griffiths","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2010.374","article-title":"Renal cell carcinoma may evade the immune system by converting CD4+Foxp3- T cells into CD4+CD25+Foxp3+ regulatory T cells: role of tumor COX-2-derived PGE2","volume":"3","author":"Li","year":"2010","journal-title":"Mol Med Rep"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.11.091","article-title":"Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination","volume":"72","author":"Perry","year":"2008","journal-title":"Urology"},{"key":"B193","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41419-024-07191-7","article-title":"PD-L2 of tumor-derived exosomes mediates the immune escape of cancer cells via the impaired T cell function","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104829","article-title":"Exosomal noncoding RNAs in renal cell carcinoma: mechanisms, roles, and therapeutic potential","volume":"213","author":"Zhu","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1530\/erc-20-0457","article-title":"Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC","volume":"28","author":"Turco","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27639","article-title":"Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis","volume":"132","author":"Choi","year":"2013","journal-title":"Int J Cancer"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-18-3661","article-title":"Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab","volume":"25","author":"De Giorgi","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyu193","article-title":"Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma","volume":"45","author":"Kaneko","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1159\/000318988","article-title":"Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma","volume":"85","author":"Naya","year":"2010","journal-title":"Urol Int"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.02.012","article-title":"Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): progression-free survival by independent review and overall survival update","volume":"94","author":"Choueiri","year":"2018","journal-title":"Eur J Cancer"},{"key":"B201","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1634\/theoncologist.2010-0227","article-title":"Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents","volume":"16","author":"Ladoire","year":"2011","journal-title":"Oncologist"},{"key":"B202","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/kca-180047","article-title":"Targeted therapy and immunotherapy: effect of body mass index on clinical outcomes in patients diagnosed with metastatic renal cell carcinoma","volume":"3","author":"Bergerot","year":"2019","journal-title":"Kidney Cancer"},{"key":"B203","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.1016\/j.clgc.2023.05.006","article-title":"Relationship between pretreatment body composition and clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line ipilimumab plus nivolumab","volume":"21","author":"McManus","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"B204","doi-asserted-by":"publisher","first-page":"291.e27","DOI":"10.1016\/j.urolonc.2024.04.008","article-title":"Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma","volume":"42","author":"Ishihara","year":"2024","journal-title":"Urol Oncol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1097\/ju.0000000000001377","article-title":"A systematic review and meta-analysis of the significance of body mass index on kidney cancer outcomes","volume":"205","author":"Kim","year":"2021","journal-title":"J Urol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1161\/CIR.0b013e318233bc6a","article-title":"Assessing adiposity","volume":"124","author":"Cornier","year":"2011","journal-title":"Circulation"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2023.09.002","article-title":"Differences in the levels of inflammatory markers between metabolically healthy obese and other obesity phenotypes in adults: a systematic review and meta-analysis","volume":"34","author":"Su","year":"2024","journal-title":"Nutrition Metab Cardiovasc Dis"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24210","article-title":"Association of body mass index with mortality and postoperative survival in renal cell cancer patients, a meta-analysis","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1159\/000520833","article-title":"Body mass index, sarcopenia, and their variations in predicting outcomes for patients treated with nivolumab for metastatic renal cell carcinoma","volume":"100","author":"Herrmann","year":"2022","journal-title":"Oncology"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.1979","article-title":"Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma","volume":"8","author":"Mano","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0213","article-title":"Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy","volume":"16","author":"Steffens","year":"2011","journal-title":"Oncologist"},{"key":"B212","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2147\/CMAR.S230973","article-title":"The prognostic value of body fat components in metastasis renal cell carcinoma patients treated with TKIs","volume":"12","author":"Dai","year":"2020","journal-title":"Cancer Manage Res"},{"key":"B213","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semcancer.2023.06.001","article-title":"Obesity and renal cell carcinoma: biological mechanisms and perspectives","volume":"94","author":"Venkatesh","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.Epi-16-0226","article-title":"Body mass index and survival in a prospective randomized trial of localized high-risk renal cell carcinoma","volume":"25","author":"Donin","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.512","article-title":"Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma","volume":"109","author":"Ohno","year":"2013","journal-title":"Br J Cancer"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.03.186","article-title":"Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells","volume":"180","author":"Horiguchi","year":"2008","journal-title":"J Urol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-22-2661","article-title":"Obesity is associated with altered tumor metabolism in metastatic melanoma","volume":"29","author":"Hahn","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"key":"B219","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41467-024-47359-5","article-title":"Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk","volume":"15","author":"Piening","year":"2024","journal-title":"Nat Commun"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193139","article-title":"A review of immunotherapy in renal cell carcinoma: current landscape and future directions","volume":"17","author":"Peshin","year":"2025","journal-title":"Cancers"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004316","article-title":"Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma","volume":"10","author":"Motzer","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B222","doi-asserted-by":"publisher","first-page":"15","DOI":"10.17305\/bjbms.2022.7953","article-title":"PD-L1 testing by immunohistochemistry in immuno-oncology","volume":"23","author":"Vranic","year":"2023","journal-title":"Biomol BioMed"},{"key":"B223","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ccell.2020.10.011","article-title":"Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade","volume":"38","author":"Motzer","year":"2020","journal-title":"Cancer Cell"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228633","article-title":"Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk","volume":"15","author":"Elisia","year":"2020","journal-title":"PloS One"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1487-6","article-title":"Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma","volume":"62","author":"Santoni","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-11-1261","article-title":"Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway","volume":"71","author":"Daurkin","year":"2011","journal-title":"Cancer Res"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21620","article-title":"Obesity alters immune and metabolic profiles: new insight from obese-resistant mice on high-fat diet","volume":"24","author":"Boi","year":"2016","journal-title":"Obes (Silver Spring)"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.3158","article-title":"Clinical validation of PBRM1 alterations as a marker of immune checkpoint inhibitor response in renal cell carcinoma","volume":"5","author":"Braun","year":"2019","journal-title":"JAMA Oncol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5951","article-title":"Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma","volume":"359","author":"Miao","year":"2018","journal-title":"Science"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_430734","article-title":"Update on biomarkers in renal cell carcinoma","volume":"44","author":"Saliby","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B231","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/cancers13030477","article-title":"Therapeutic strategies for targeting IL-1 in cancer","volume":"13","author":"Gottschlich","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1866875\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:46:42Z","timestamp":1781156802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1866875\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":231,"alternative-id":["10.3389\/fimmu.2026.1866875"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1866875","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"article-number":"1866875"}}